RU92004370A - PHTHALASINE DERIVATIVES, METHOD OF THEIR PRODUCTION AND MEDICINES ON THEIR BASIS - Google Patents
PHTHALASINE DERIVATIVES, METHOD OF THEIR PRODUCTION AND MEDICINES ON THEIR BASISInfo
- Publication number
- RU92004370A RU92004370A RU92004370/04A RU92004370A RU92004370A RU 92004370 A RU92004370 A RU 92004370A RU 92004370/04 A RU92004370/04 A RU 92004370/04A RU 92004370 A RU92004370 A RU 92004370A RU 92004370 A RU92004370 A RU 92004370A
- Authority
- RU
- Russia
- Prior art keywords
- residue
- alkyl
- pyridyl
- phenyl
- substituted
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 1
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N Phthalazine Chemical class C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000005236 alkanoylamino group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000006383 alkylpyridyl group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Chemical group 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
Claims (1)
где Х обозначает кислород или серу и остаток R представляет остаток хинуклидила, С1 - С6 -алкильный остаток, остаток фенила, остаток пиридила, замещенный остатками R1, R2 и/или R3 остаток фенила или пиридила, замещенный пиридилом или алкилпиридилом С1 - С6 -алкильный остаток или замещенный фенилом С1 - С6 -алкильный остаток, причем этот остаток фенила может быть замещен также остатками R1, R2 и/или R3, и остатки R1, R2 и R3 одинаковые или различные и обозначают водород, галоген, ригалогенметил, С1 - С6-алкил, С1 - С6 -алкокси, карбокси, карб-С1 - С6 -алкокси, амино, С1 - С6 -алкиламино, С1 - С6 -диалкиламино, С1 - С6 -триалкиламино, С2 - С6 - алканоиламино или С2 - С6 -алканоиламино, который в алкильной части содержит еще аминогруппу, и их физиологически совместимые кислые аддитивные соли, способ их получения и лекарственное средство на их основе.Pharmacologically effective phthalazine derivatives of general formula (I) are provided.
where X is oxygen or sulfur and the residue R represents a quinuclidyl residue, a C 1 -C 6 -alkyl residue, a phenyl residue, a pyridyl residue substituted by R 1 , R 2 and / or R 3 residues of a phenyl or pyridyl residue substituted by pyridyl or alkyl pyridyl C 1 - C 6 -alkyl residue or substituted with phenyl C 1 - C 6 -alkyl residue, and this phenyl residue may also be substituted by residues R 1 , R 2 and / or R 3 , and residues R 1 , R 2 and R 3 are the same or different and denote hydrogen, halogen, rihalogenmethyl, C 1 - C 6 -alkyl, C 1 - C 6 -alkoxy, carboxy, carb-C 1 - C 6 -alko Xi, amino, C 1 - C 6 alkylamino, C 1 - C 6 dialkylamino, C 1 - C 6 -trialkilamino, C 2 - C 6 - alkanoylamino or C 2 - C 6 alkanoylamino which the alkyl portion contains more an amino group, and their physiologically compatible acid addition salts, a method for their preparation and a medicament based thereon.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4135910.0 | 1991-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU92004370A true RU92004370A (en) | 1995-08-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2070994T3 (en) | DOPAMINE PROFARMACO. | |
DE68901153D1 (en) | DERIVATIVES OF PURIN, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION. | |
EP0671390A3 (en) | Antithrombotic agents | |
ES2051834T3 (en) | THE USE OF TETRAHYDROBENZENE (C, D) INDOL-6 CARBOXAMIDES FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF ANXIETY. | |
EP0138344A3 (en) | Pyridazinones as beta-adrenoceptor antagonists | |
KR930007914A (en) | Phthalazine containing ether or thioether group in the first position and preparation method thereof | |
NO852514L (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 8-ALKYLTIO-2-PIPERAZINO-PYRIMIDO (5,4-D) PYRIMIDINE DERIVATIVES. | |
AR245125A1 (en) | Procedure for the preparation of arylpiperazinyl-alkylenphenyl-p-heterocyclic compounds and their pharmaceutically acceptable salts from acid addition. | |
EP0314275A3 (en) | 2-pyrrolidone-5-carboxylic acid compounds | |
RU92004370A (en) | PHTHALASINE DERIVATIVES, METHOD OF THEIR PRODUCTION AND MEDICINES ON THEIR BASIS | |
NO930353L (en) | ENZOIC ACID DERIVATIVES, THE PROCEDURE FOR THEIR PREPARATION AND USE THEREOF | |
PT855398E (en) | SASQUITERPENE DERIVATIVES HAVING ANTIVIRAL ACTIVITY | |
EP0218953A3 (en) | Derivatives of 19,20-bis-nor-prostanoic acid with antiulcer and anorectic activity, process for their preparation and pharmaceutical compositions thereof | |
GB2145719B (en) | Flavene and thioflavene derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter | |
DE68922605D1 (en) | Process for the preparation of (-) 2- (2- (2-aminoethoxy) ethoxy) methyl) -4- (2,3-dichlorophenyl) -3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine, and intermediate for its manufacture. | |
ES2004255A6 (en) | PHARMACOLOGICALLY ACTIVE OCTAHYDRO-PYRIDO(1,2-a) PYRAZINES. | |
DK189291A (en) | 3H-PURIN-2,6-DIONE DERIVATIVES AND SALTS THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AND PREPARATION OF DERIVATIVES AND PREPARATIONS | |
RU94033356A (en) | NEW TETRAHYDRONAPTALINE DERIVATIVES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND METHOD FOR ITS PRODUCTION | |
ATE73326T1 (en) | USE OF L-CARNITINE IN THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF TOXIC EFFECTS INDUCED BY THE INHALATION OF HALOTENE AND OTHER HALOGEN-CONTAINING GENERAL ANESTHETICS. | |
RU94019332A (en) | 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO / 1,2-A / PIRASINS, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |